Vitafol-OB Caplet By Exeltis USA Overview & Drug Interactions

Check For Interactions With Vitafol-OB Caplet

Supplement: Vitafol-OB Caplet by Exeltis USA

Vitafol-OB Caplet Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Vitafol-OB Caplet by Exeltis USA

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Pregnant and Lactating
Minimum serving Sizes:
1 Not Present
Maximum serving Sizes:
1 Not Present

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin A
2700 IU
Vitamin A
Vitamin C
70 mg
Vitamin C
Vitamin D3
400 IU
Vitamin D
Vitamin E
30 IU
Vitamin E
Thiamine Mononitrate
1.6 mg
Thiamin
Riboflavin
1.8 mg
Riboflavin
Niacin
18 mg
Niacin
Vitamin B6
2.5 mg
Vitamin B6
Folic Acid
1 mg
Folate
Vitamin B12
12 mcg
Vitamin B12
Calcium
100 mg
Calcium
Iron
65 mg
Iron
Magnesium
25 mg
Magnesium
Zinc
25 mg
Zinc
Copper
2 mg
Copper

Other Ingredients:
Microcrystalline Cellulose
hydrolyzed Gelatin
Forms
  • Pig skin
modified Cellulose Gum
Stearic Acid
Hydroxypropylmethylcellulose
Titanium Dioxide
Polydextrose
Silicon Dioxide
Gelatin
Magnesium Stearate
modified Food Starch
Sucrose
Maize Starch
Triacetin
Dibasic Calcium Phosphate
Hydroxypropylcellulose
FD&C Blue #1 Aluminum Lake
Polyethylene Glycol
Sodium Ascorbate
Tocopherol concentrate
FD&C Blue #2 Aluminum Lake
Medium Chain Triglycerides
Sorbic Acid
Tribasic Calcium Phosphate
Sodium Benzoate
DL-Alpha-Tocopherol


Label Statments:


General Statements
- 0642-0076-30
- Composition:
- How supplied: Vitafol-OB+DHA is available as a light blue caplet debossed EV0079 and one amber-colored DHA softgel capsule. Available in Box of Unit-Dose pack of 30 (6 child resistant blister cards of 5 caplets and 5 softgel capsules each), (0642-0076-30) and as professional samples (0642-0076-03).
- Rev. November 2018
FDA Statement of Identity
- Prenatal Supplement with DHA Rx
Precautions
- Contains: Soy.
- Contraindications: Vitafol-OB+DHA is contraindicated in patients with hypersensitivity to any of its components or color additives. Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. Iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin B-12).
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.
- Warnings/Precautions: Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues. Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur. Prolonged use of iron salts may produce iron storage disease. Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive. The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency. Avoid overdosage.
- Keep out of the reach of children.
- Drug interactions: High doses of folic acid may result in decreased serum levels of the anticonvulsant drugs. Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. Zinc can inhibit the absorption of certain antibiotics; take at least 2 hours apart to minimize interactions. Consult appropriate references for additional specific vitamin-drug interactions.
- Information for patients: Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breast-feeding.
- Pediatric use: Not for pediatric use.
- Adverse reactions: Adverse reactions have been reported with specific vitamins and minerals, but generally at doses substantially higher than those in Vitafol-OB+DHA.
- Allergic reactions have been reported with some forms of gum acacia to include respiratory problems and skin lesions.
Formula
- Indications and usage: Vitafol-OB+DHA is indicated to provide vitamin, mineral and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother, including individuals with known allergies to fish.
Formulation
- Vitafol-OB+DHA does not contain fish, fish oils, fish proteins or fish byproducts.
Suggested/Recommended/Usage/Directions
- Dosage and administration: Before, during and after pregnancy, one caplet and one soft-gel capsule daily, or as directed by a physician.
Storage
- Store at room temperature, approximately 15 degrees - 30 degrees C (59 degrees - 86 degrees F), avoid excessive heat and moisture.
Brand IP Statement(s)
- 2018 Exeltis USA, Inc. U.S. Patent No. 6,814,983; 7,390,509 Vitafol is a trademark of Exeltis USA, Inc.

Brand Information

See all products by this brand

Distributed by
Name Exeltis USA, Inc.
City Florham Park
State NJ
Country USA
ZipCode 07932
Phone Number 1-877-324-9349
Web Address www.exeltisusa.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.